Singapore markets close in 5 hours 41 minutes
Straits Times Index
3,313.85 +0.37 (+0.01%) Nikkei
39,346.92 +559.54 (+1.44%) Hang Seng
19,624.45 +70.84 (+0.36%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,652.04 -500.45 (-0.75%) CMC Crypto 200
1,362.33 -11.51 (-0.84%)
Pieris Pharmaceuticals Inc (PI6.MU)
Munich - Munich Delayed price. Currency in EUR
Add to watchlist
At close: 08:02AM CEST
| Previous close | 0.15 |
| Open | 0.15 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.15 - 11.70 |
| 52-week range | 0.15 - 68.88 |
| Volume | |
| Avg. volume | 2 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 29 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Investors Don't See Light At End Of Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Tunnel And Push Stock Down 27%
To the annoyance of some shareholders, Pieris Pharmaceuticals, Inc. ( NASDAQ:PIRS ) shares are down a considerable 27...
ZacksPieris Pharmaceuticals (PIRS) Upgraded to Strong Buy: Here's Why
Pieris Pharmaceuticals (PIRS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ZacksPieris (PIRS) Pursues Strategic Alternatives, Stock Rises
Pieris (PIRS) announces strategic update after partner AstraZeneca terminated collaboration agreement and returned the rights to elarekibep.
© 2024 Yahoo. All rights reserved.